G6PD and colorectal carcinoma: Responding to ROS, NRF2 plays a vital role in transcriptionally regulating the expression of antioxidants genes including G6PD.17, 18 Immunoblotting analysis indicated that oxaliplatin treatment induced NFR2 activation and G6PD expression in CRC cells (Figure 3b).